NASDAQ · Medical - Devices

AMIX (AMIX) Stock

$12.10 -37.95% NASDAQ: AMIX Healthcare

Valuation

MetricValue
Price$12.10
Market Cap$6.57M
P/E Ratio-0.17
P/B Ratio0.75
P/S Ratio0.00
EPS (TTM)$-2.32
52-Week High$12.10
52-Week Low$0.20
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-238.89%
ROA-1.22%
ROCE-283.33%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.00

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-14.0M$-2.0M$-12.0M$-12.0M$-17.0M
Net Profit$-13.0M$-2.0M$-15.0M$-11.0M$-17.0M
EPS$-0.71$-0.11$-21.09$-6.46$-2.32
Op Margin—————

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$2.0M$1.0M$9.0M$10.0M$8.0M
Total Liabilities$0$0$2.0M$2.0M$2.0M
Cash$2.0M$1.0M$9.0M$9.0M$7.0M
Borrowings$0$0$1.0M$0$0

Latest News

Autonomix Medical Receives US Patent Covering Neural Sensing Technology for Overactive Bladder MT Newswires · Jul 15, 2026 Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform GlobeNewswire · Jul 15, 2026 Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules GlobeNewswire · Jul 14, 2026 Autonomix Medical Receives Canadian Patent for Neural Sensing Technology MT Newswires · Jul 13, 2026 Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant GlobeNewswire · Jul 13, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$0$-2.0M$-7.0M$-8.0M$-12.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$-1.0M$-1.0M$8.0M
Net Cash Flow$2.0M$-1.0M$8.0M$1.0M$-2.0M
Free Cash Flow$0$-2.0M$-7.0M$-8.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.15
FCF Yield-560.45%
Quick Ratio4.45
Interest Coverage—
Return 1Y-82.80%
Return 3Y—
Return 5Y—

Ownership

Insiders Held4.11%
Institutions Held4.22%
Institutions Float Held4.40%
Institutional HolderSharesReport Date
Geode Capital Management, LLC8,3632026-03-31
Mariner, LLC2,5202026-03-31
UBS Group AG1,5952026-03-31
LPL Financial LLC1,4972026-03-31
Bank of Montreal /CAN/1,1902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIM $0.24 -5.84% -0.09 $801193 0.00%
BBLG $1.02 -4.21% -1.10 $1.84M 0.00%
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
HSCS $2.18 +4.81% -0.70 $4.71M 0.00%

About AMIX

AMIX is led by CEO Bradley Hauser, employs 5 people, headquartered in US, publicly traded since 2024.

AMIX stock trades at $12.10 with a market capitalization of $6.57M. The stock is valued at a price-to-earnings (P/E) ratio of -0.17, price-to-book of 0.75, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.20 and $12.10, and currently trades at its 52-week high.

On profitability, AMIX generates a return on equity (ROE) of -238.89%, return on capital employed of -283.33%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides